You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


MHRA authorises Moderna’s omicron-containing bivalent booster

Moderna has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted conditional authorisation for the use of Omicron-containing bivalent COVID-19 booster vaccine, mRNA-1273.214